EWIC, March 14-16, 2019

11/02/2019

We are happy to announce that Omixon is one of the Silver Sponsors of this year’s EWIC Conference in Zagreb, Croatia. Title of our talk: “Donor selection for solid organ transplantation guided by NGS high resolution HLA typing in combination with PIRCHE “ Date: Friday, March 15, 2019 Time:...

THIS IS US: A Letter from CEO, Dr. Peter Meintjes

31/01/2019

Dear Customers and Friends of Omixon, Cue the emotion-grabbing drawn-out string music, cue the slow motion, zoomed-in camera shots focused on faces to capture the true depth of the feelings of the moment, and cue the hazy image filters that send you into the story telling time machine of...

Holotype HLA Validation on Illumina’s MiniSeq

31/01/2019

Introduction The Illumina NGS sequencing fleet includes instruments of different sample capacity. One of them is the MiniSeq – designed for laboratories with a small to medium sample throughput. Omixon’s Holotype HLA was initially developed and validated for Illumina’s MiSeq, as this is a commonly available instrument in clinical...

MEDLAB Dubai, February 4-7, 2019

28/01/2019

Omixon is attending the upcoming MEDLAB Conference in Dubai. Learn more about the event here… Contact sales@omixon.com for more information.

Omixon and Algimed Sign Partnership Agreement

14/01/2019

At Omixon we are working hard to expand our customer base and it is always a pleasure and excitement to share the news of new collaborations, partnerships and distribution agreements. This time we are happy to announce that with the help of the Minsk-based Algimed, Omixon is now represented...